Factor V‐short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors
Authors:
Open Access
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 2 (1) , 114-124
Abstract
No abstract availableKeywords
Funding Information
- Vetenskapsrådet
- Söderberg's Foundation
- Hjärt-Lungfonden
This publication has 42 references indexed in Scilit:
- Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorderJournal of Clinical Investigation, 2013
- Coagulation factor VA2440G causes east Texas bleeding disorder via TFPIαJournal of Clinical Investigation, 2013
- TFPI-dependent activities of Protein SThrombosis Research, 2012
- The Kunitz-3 domain of TFPI-α is required for protein S–dependent enhancement of factor Xa inhibitionBlood, 2010
- Protein S as Cofactor for TFPIArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- The molecular basis of factor V and VIII procofactor activationJournal of Thrombosis and Haemostasis, 2009
- Regulation of TFPI function by protein SJournal of Thrombosis and Haemostasis, 2009
- Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiencyBlood, 2008
- Advances in understanding pathogenic mechanisms of thrombophilic disordersBlood, 2008
- Thrombin-mediated Proteolysis of Factor V Resulting in Gradual B-domain Release and Exposure of the Factor Xa-binding SiteJournal of Biological Chemistry, 2002